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Abstract
The lacrimal gland plays a pivotal role in keeping the ocular surface lubricated, and protecting it 
from environmental exposure and insult. Dysfunction of the lacrimal gland results in deficiency of 
the aqueous component of the tear film, which can cause dryness of the ocular surface, also known 
as the aqueous-deficient dry eye disease. Left untreated, this disease can lead to significant 
morbidity, including frequent eye infections, corneal ulcerations and vision loss. Current therapies 
do not treat the underlying deficiency of the lacrimal gland, but merely provide symptomatic 
relief. To develop more sustainable and physiological therapies, such as in vivo lacrimal gland 
regeneration or bioengineered lacrimal gland implants, a thorough understanding of lacrimal gland 
development at the molecular level is of paramount importance. Based on the structural and 
functional similarities between rodent and human eye development, extensive studies have been 
undertaken to investigate the signaling and transcriptional mechanisms of lacrimal gland 
development using mouse as a model system. In this review, we describe the current understanding 
of the extrinsic signaling interactions and the intrinsic transcriptional network governing lacrimal 
gland morphogenesis, as well as recent advances in the field of regenerative medicine aimed at 
treating dry eye disease.
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Overview of the lacrimal gland
The lacrimal gland is a tubulo-acinar exocrine gland that produces the aqueous component 
of the tear film, including water, electrolytes and proteins (Zoukhri, 2010). Critical for 
ocular health and quality vision, the tear film forms a smooth refractive layer over the 
cornea, while lubricating the cornea and conjunctiva, supporting ocular surface metabolism, 
and flushing away dirt and noxious stimuli. This film is composed of three layers: 1) the 
outermost lipid layer secreted by Meibomian glands that prevents evaporation of tears, 2) the 
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middle aqueous layer produced by the lacrimal gland that accounts for over 90% of tear 
volume, and 3) the innermost mucous layer produced by goblet cells of the conjunctiva that 
anchors the tear film to the ocular surface (Johnson and Murphy, 2004). By releasing 
immunoglobulins into the tears, the lacrimal gland also functions as a secretory immune 
system to protect the ocular surface against infection (Holly and Lemp, 1977).
In humans, the primary lacrimal gland is located within the upper temporal orbit, emptying 
its secretions into an anastomosed duct system that delivers the fluid to the ocular surface. 
The outflow component of the lacrimal system lies at the nasal side of the eye, where puncta 
located on the upper and lower lids drain fluid into canaliculi leading to the nasolacrimal sac 
and nose (Figure 1) (Walcott, 1998). In rodents, however, the lacrimal gland is comprised of 
two lobular structures: one intra-orbital and the other extra-orbital. The primary lacrimal 
gland is the extra-orbital lobe, located just beneath the ear and connected to the eye via a 
long duct that joins the intra-orbital lobe just prior to reaching the eye (Figure 2) (Dartt, 
2009). The lacrimal gland epithelium is composed of three major cell types: acinar, ductal 
and myoepithelial cells. The primary secretory apparatus is composed of acinar cells, which 
make up to 80% of the gland. The luminal sides of the acinar cells are connected to the 
secretory ducts lined by cuboidal duct cells, which constitute 10–12% of the lacrimal gland 
cell population and contribute to 30% of the lacrimal gland fluid secretions (Mircheff, 1989). 
Myoepithelial cells surround the basal side of both acinar and ductal cells. Their function is 
to apply pressure to the secretory cells to expel the fluid into the duct (Dartt, 2009). Besides 
these three main cell types, the lacrimal gland stroma also contains fibroblasts that produce 
collagens, and mast cells that secrete histamines and matrix proteins into the interstitial 
spaces (Walcott, 1998). The vasculature of the lacrimal gland also brings in plasma cells, 
lymphocytes, dendritic cells and macrophages, which provide immune protection to the 
ocular surface (Allansmith et al., 1976; Dartt, 2009). The function of the lacrimal system is 
controlled by sensory afferent nerves from the cornea and conjunctiva, coupled with 
parasympathetic and sympathetic efferent nerves innervating the lacrimal gland. These 
nerves ensure an optimum volume and quality of tear secretion in response to environmental 
stress (Dartt, 2009).
Impairment of lacrimal gland function can result in the debilitating condition known as 
aqueous-deficient dry eye disease, which can progress to corneal ulceration and vision loss if 
left untreated. The most significant risk factor for dry eye disease is aging, associated with 
structural and functional changes in the lacrimal gland characterized by atrophied acini, duct 
obstruction, lymphocytic infiltration and decreased protein secretion (Rocha et al., 2008). 
Lacrimal gland dysfunction can also arise from inflammation triggered by the dry 
environment, auto-immune attack as in Sjogren’s syndrome and rheumatoid arthritis, side 
effects of chemo and radiation therapies, as well as congenital defects (Javadi and Feizi, 
2011; He et al., 2013; Park et al., 2015). Several treatments exist, including punctal 
occlusion to reduce tear drainage, anti-inflammatory drugs such as topical cyclosporine and 
lifitegrast, and most commonly artificial tears and gels (Babic et al., 2010). However, each of 
these clinical interventions are primarily palliative, and are not aimed at curing the 
underlying lacrimal gland deficiency. To this end, regeneration of the damaged lacrimal 
gland or replacement by bioengineered implants can potentially provide long lasting and 
physiological cures for dry eye disease. Ensuring the success of these approaches will 
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require a thorough understanding of the molecular mechanism of lacrimal gland 
development and regeneration. In this review, we will focus on signaling pathways and 
transcription factors that have been shown to regulate lacrimal gland development in animal 
models and discuss emerging regenerative therapies that may ultimately provide more 
sustainable treatment for the dry eye disease.
The molecular mechanism of lacrimal gland development
Signaling interactions: the epithelium-mesenchyme interaction
The lacrimal gland forms as a result of interactions between the conjunctival epithelium and 
the periocular mesenchyme. In humans, it begins as a thickening of the epithelium at the 
superior conjunctival fornix, which subsequently invades the underlying mesenchyme to 
form a highly branched gland (de la Cuadra-Blanco et al., 2003). This is recapitulated in 
mouse as the budding of the conjunctival epithelium at the temporal side of the eye at the 
E13.5 stage (Figure 2) (Makarenkova et al., 2000). This tubular bud elongates dorsally 
toward the ear, accompanied by condensation of the surrounding mesenchyme (Dean et al., 
2004). This process can occur independently of retina and lens development, as the lacrimal 
gland bud develops even in mouse mutants lacking the eyeball (Swindell et al., 2008). 
Starting at E16.5, the lacrimal gland bud branches out to form a complex intra-orbital and 
extra-orbital multi-lobular structure, eventually becoming composed of a system of acini, 
ducts, myoepithelial cells, nerves, plasma cells and connective tissues.
The inductive signals to initiate lacrimal gland budding and branching morphogenesis are 
Fibroblast Growth Factors (FGFs). Fgf10 in particular is expressed in a distinctive domain in 
the mesenchyme surrounding the epithelial bud and its expression persists throughout 
lacrimal gland development. By contrast, Fgf7 expression in the mesenchyme is more 
diffused (Govindarajan et al., 2000; Makarenkova et al., 2000). Both recombinant human 
FGF10 and FGF7 were able to induce ectopic budding of the lacrimal gland epithelium in 
explant cultures of the mouse embryonic eye (Makarenkova et al., 2000). Remarkably, 
ectopic glands can even be induced in the cornea by transgenic expression of either rat Fgf10 
or human FGF7 in the lens, but not by other FGFs, underscoring the potency and specificity 
of the FGF7/10 subfamily of FGFs for lacrimal gland development (Lovicu et al., 1999; 
Govindarajan et al., 2000). Fgf10 null mice exhibit a complete loss of the epithelial 
component of the lacrimal gland despite an intact mesenchyme, while Fgf7 knockout mice 
have normal lacrimal glands, indicating that Fgf10 is the primary driver of lacrimal gland 
development (Lovicu et al., 1999; Govindarajan et al., 2000; Makarenkova et al., 2000). 
Further, Fgf10 is haploinsufficient for lacrimal gland development in both mice and humans, 
in which a heterozygous loss of function mutation can lead to aplasia of the lacrimal and 
salivary glands (ALSG), a rare disorder characterized by dryness of the eye and mouth 
(OMIM #180920) (Entesarian et al., 2005). A more severe congenital disorder called 
Lacrimo-auriculo-dento-digital (LADD) syndrome affecting lacrimal and salivary glands, 
ears, teeth and distal limbs has been associated with missense mutations in FGF10 (OMIM 
#149730) (Rohmann et al., 2006). The majority of LADD mutations result in the disruption 
of FGF10 protein stability or its capacity to interact with its receptor, but missense mutations 
affecting secretion and nuclear localization of FGF10 have also been identified (Shams et 
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al., 2007; Mikolajczak et al., 2016). These FGF10 mutations are thought to exert a 
dominant-negative effect instead of simple loss-of-function, which may explain why more 
organs are affected in LADD syndrome than in ALSG syndrome (Rohmann et al., 2006). 
These phenotypes highlight the pivotal role of FGF10/Fgf10 in multi-organ development, 
but also raise the interesting question of why lacrimal gland development is particularly 
sensitive to their gene dosage.
In addition to the precise control of Fgf10 at the transcriptional level, the concentration of 
Fgf10 protein in the periocular mesenchyme is also under exquisite regulation by 
proteoglycans within the extracellular matrix (ECM) (Figure 3) (Balasubramanian and 
Zhang, 2016). Previous work from our lab has shown that glycosaminoglycans (GAGs) 
attached to proteoglycans in the periocular mesenchyme restricts the diffusion of Fgf10 
during lacrimal gland development (Qu et al., 2012). Mesenchyme-specific knockouts of the 
proteoglycan biosynthetic enzyme UDP-Glucose 6-Dehydrogenase (Ugdh) cause excessive 
diffusion of Fgf10 that is found to disrupt lacrimal gland budding. Interestingly, the lacrimal 
gland defect can also be produced by mesenchymal specific deletion of heparan sulfate 
(proteoglycan) modification enzymes N-deacetylase/N-sulfotransferase (Ndst1/2), but not by 
2-O-sulfotransferases (Hs2st) and 6-O-sulfotransferases (Hs6st1/2), suggesting that N-
sulfation of heparan sulfates is essential for regulating Fgf10 compartmentalization (Qu et 
al., 2012). Consistent with this model, mutating the key residues of FGF10 that interact with 
heparan sulfates also resulted in an increased diffusion range of FGF10 in the ECM 
(Makarenkova et al., 2009). The mutant FGF10 was found to behave like FGF7, which has a 
lower affinity for heparan sulfates and preferentially promotes lacrimal gland branching 
instead of elongation.
FGF signaling has been shown to cooperate with the transcription factor Barx2 in the 
lacrimal gland epithelium to regulate the expression of two matrix metalloproteinases 
(MMP2 and MMP9) involved in ECM remodeling and are secreted into the mesenchyme to 
promote the release of Fgf10 from proteoglycans (Tsau et al., 2011). This presents a positive 
feedback mechanism to modulate the Fgf10 concentration ahead of the invading epithelial 
bud. One question that remains unresolved is whether the control of Fgf10 diffusion by 
proteoglycans generates a chemokine gradient to spatially guide lacrimal gland 
development. Answering this question is hampered by the lack of a sensitive assay to 
determine the endogenous concentration of Fgf10 in the periocular mesenchyme. In this 
regard, it is worth noting that although endogenous Fgf10 is also expressed in a localized 
fashion in the embryonic lung, a recent study showed that it can be functionally substituted 
by ubiquitous expression of Fgf10 during branching morphogenesis (Volckaert et al., 2013). 
This raises the possibility that an Fgf10 gradient may not be an absolute requirement for the 
budding and branching of glandular organs.
Biochemical studies have determined that the specific receptor for Fgf10 is Fgf receptor 
2(III)b (Fgfr2b), which is expressed in the lacrimal gland epithelium (Makarenkova et al., 
2000; Zhang et al., 2006). Indeed, both epithelial ablation of Fgfr2 in vivo, as well as ex vivo 
knock down of Fgfr2b, disrupts lacrimal gland development (Makarenkova et al., 2000; Pan 
et al., 2008). Interestingly, LADD syndrome can be caused by either FGFR2 or FGFR3 
missense mutations, both of which are assumed to be hypomorphic given that affected 
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patients do not exhibit the typical gain-of-function FGF signaling phenotypes (Rohmann et 
al., 2006). This observation is in apparent conflict with both the low affinity of Fgfr3 toward 
Fgf10 in vitro, and the lack of a lacrimal gland defect in Fgfr3 knockout mice (AG and XZ, 
unpublished results). A functional study is needed to resolve the nature of the LADD-
associated FGFR3 mutations. It is also interesting to note that heterozygous ablation of 
Fgfr2c, which is not the canonical receptor for Fgf10, results in secondary branching defects 
in the lung, kidney and lacrimal gland (Hajihosseini et al., 2001). Since the Fgfr2 
heterozygous null mouse lacks an overt phenotype, it is believed that the Fgfr2c mutant is a 
gain-of-function allele resulting from an alternative splicing event in the Fgfr2 locus, leading 
to ectopic expression and activation of Fgfr2b in the mesenchyme. Although the Fgfr2c 
mutant lacrimal gland retains a mesenchymal sac without Fgf10 expression, it remains to be 
determined how aberrant Fgfr2b signaling can be activated without Fgf10 in the 
mesenchyme.
The assembly of an FGF signaling complex on the cell surface requires heparan sulfates as 
co-receptors (Figure 3). Interestingly, the lacrimal gland bud specifically expresses Ndst1 
enzyme in the tip cells, but not in the follower cells that form its stalk (Pan et al., 2008). 
Ablation of Ndst1 in the epithelium not only disrupts N-sulfation of heparan sulfates, but 
also abrogates lacrimal gland budding. Similarly, 2-O and 6-O sulfation of heparan sulfates 
each contribute to Fgf10-induced signaling given that the deletions of Hs6st and Hs2st in the 
lacrimal gland epithelium resulted in either stunted growth or no bud formation (Qu et al., 
2011). Indeed, using a FGF ligand and carbohydrate engagement assay (LACE), we showed 
that recombinant Fgf10/Fgfr2b proteins were able to form a tight binding complex on the 
lacrimal gland bud in situ, which was disrupted in heparan sulfate N- or O-sulfation mutants 
(Pan et al., 2008; Qu et al., 2011). On the other hand, these modifications of heparan sulfates 
are also under control of FGF signaling, as epithelial ablation of Fgfr2 abolished N-sulfation 
of heparan sulfates (Pan et al., 2008). This positive feedback mechanism is mediated by 
Shp2, a non-receptor tyrosine phosphatase that transmits FGF signaling to the Ras-MAPK 
pathway, partly by inhibiting the negative Ras signaling regulator Sprouty2 (Pan et al., 
2010). The key targets of this FGF signaling cascade are likely to be the transcription factors 
Sox9 and Sox10, which have been shown to regulate the expression of heparan sulfate 3-O-
sulfotransferases in an FGF-signaling-dependent manner (Chen et al., 2014b).
While Fgf10 is expressed exclusively in the lacrimal gland mesenchyme to guide budding 
and branching of the epithelium, another growth factor, Bmp7, displays a more complex and 
dynamic expression pattern during lacrimal gland development. Initially expressed in the 
periocular mesenchyme surrounding the epithelial bud, Bmp7 is later present in both the 
epithelial and mesenchymal compartments of the lacrimal gland (Dean et al., 2004). The 
primary target of Bmp7 signaling, however, appears to be the lacrimal gland mesenchyme. 
Exposing isolated lacrimal gland epithelium to Bmp7 does not affect budding induced by 
Fgf10, but, in a mesenchymal culture, Bmp7 resulted in increased cellular proliferation and 
aggregation marked by expression of connexin43, cadherins and α-smooth muscle actin (α-
SMA) (Dean et al., 2004). In contrast, defective condensation of the periocular mesenchyme 
was found in Bmp7 null mice, which also exhibited smaller glands with misplaced buds and 
reduced branching. It is thought that the condensation and proliferation of mesenchymal 
cells induced by BMP signaling is critical for proper branching morphogenesis of the 
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lacrimal gland epithelium. In support of this concept, it was shown that transcription factor 
Foxc1 was dispensable in the lacrimal gland epithelium, but its loss in the mesenchyme 
prevented BMP signaling from inducing cellular condensation (Mattiske et al., 2006). As a 
result, Foxc1 null mice exhibited reduced lacrimal gland size with fewer terminal buds, 
reminiscent of the Bmp7 null phenotype. In contrast to Bmp7, Bmp4 is found to suppress 
Fgf10-induced growth and elongation of the lacrimal gland bud in an isolated epithelial 
culture, suggesting that BMP signaling may also play a direct role in the lacrimal gland 
epithelium (Dean et al., 2004). BMP signaling is mediated by phosphorylated Smad1/5/8 
proteins, which form a complex with Smad4 to activate the downstream transcriptional 
events. Indeed, a recent study showed that epithelial deletion of Smad4 resulted in smaller 
lacrimal glands with fewer branches and acini (Liu and Lin, 2014). Interestingly, the 
lacrimal gland in Smad4 mutants accumulates pigments after birth and is eventually replaced 
by adipose tissue. These studies suggest that BMP signaling in both the epithelium and the 
mesenchyme are critical for lacrimal gland development.
Canonical Wnt signaling has been shown to interact with both FGF and BMP signaling to 
modulate lacrimal gland branching morphogenesis. Activation of the canonical Wnt 
signaling pathway prevents degradation of β-catenin in the cytoplasm, which is thereby 
translocated into the nucleus to bind Tcf/Lef transcription factors to induce gene expression. 
Transcripts of several Wnts (both canonical and non-canonical) are present in the lacrimal 
gland during development (Dean et al., 2005). Inhibition of Wnt signaling by knocking 
down β-catenin with morpholinos in lacrimal gland explants leads to increased branching 
and cell proliferation, and an up-regulation of Fgf10 in the mesenchyme. Activation of Wnt 
signaling by Wnt3a or LiCl treatment, on the other hand, reduces proliferation of both the 
epithelial and mesenchymal components of the lacrimal gland with a concurrent reduction in 
the number of branches. Wnt signaling also suppresses the Bmp7-induced increase of cell 
proliferation in the lacrimal gland mesenchyme. Thus, Wnt signaling regulates branching 
morphogenesis by counterbalancing the effects of Fgf10 and Bmp7 (Dean et al., 2005).
Maturation and homeostasis of the lacrimal gland also require Notch signaling, which acts 
through nuclear translocation of the Notch Intracellular Domain (NICD). NICD 
subsequently interacts with the recombination signal binding protein for immunoglobin Jk 
region (RBP-Jk), Histone acyl transferases, and Mastermind-like transcriptional co-activator 
(Maml), to activate transcription of target genes. Postnatal knockout of Notch1 in the ocular 
surface causes lacrimal gland degeneration with infiltration of monocytic cells, resulting in a 
marked reduction in tear volume (Zhang et al., 2013). Maml-mediated Notch signaling is 
also responsible for maintaining the conjunctival epithelial identity and goblet cell 
differentiation. This is achieved by augmenting the expression of Klf4/5 transcription factors 
to control Muc5a expression. Indeed, lacrimal gland in mice containing a Klf5 deletion in 
the epithelium exhibit excessive inflammation and disorganization of the lacrimal acini 
(Kenchegowda et al., 2011). More recently, Notch signaling has also been proposed to 
regulate branching morphogenesis by suppressing cleft-formation (Dvoriantchikova et al., 
2017). These studies suggest that Notch signaling contributes to both the development and 
function of the lacrimal gland.
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In summary, after the critical role of Fgf10 in lacrimal gland development was discovered 
less than two decades ago, it is now appreciated that FGF signaling must interact with other 
pathways, including BMP, Wnt and Notch, to regulate lacrimal gland budding and branching 
morphogenesis. Additionally, recent high throughput gene expression analysis has also 
implicated IGF, TGFβ and Hippo signaling in the human lacrimal gland (Aakalu et al., 
2017). In spite of these important findings, our understanding of essential molecular details 
remains rudimentary. For example, the lacrimal gland epithelum requires an inductive signal 
from the periocular mesenchyme, but how the mesenchyme itself is specified and whether 
the signaling is reciprocal in nature is not clear. There are also many unanswered questions 
regarding the mechanisms of FGF signaling itself. For example, why is Fgf10 particularly 
potent in inducing ectopic ocular gland, while other Fgfs, such as Fgf1, lack such activity 
(Robinson et al., 1995; Lovicu et al., 1999; Govindarajan et al., 2000)? This can not be 
entirely explained by the specificity of Fgf10 for Fgfr2b, because Fgf1 is also capable of 
activating the same receptor. Downstream of the Fgf receptor, there are multiple intracelullar 
pathways, including those mediated by Ras-MAPK, PI3K-AKT and PLC-PKC. The specific 
roles of each, and their downstream targets, are not yet well understood, and require further 
research.
Transcriptional network in lacrimal gland development
While signaling pathways transduce critical guidance information for lacrimal gland 
morphogenesis, transcription factors are the ultimate downstream interpreters and executors 
of the developmental program. The paired-domain transcription factor Pax6 is considered 
the master regulator of eye development (Gehring and Niimi, 1999). Its expression precedes 
the budding of the lacrimal gland in the fornix of the conjunctival epithelium and continues 
in the lacrimal gland epithelium throughout development. A loss of function mutation in 
even a single allele of Pax6 results in severe impairment in mouse lacrimal gland 
development, suggesting that Pax6 serves as a competence factor in the epithelium 
(Makarenkova et al., 2000). In fact, detailed characterizations of Pax6 enhancers have led to 
the development of the Le-Cre transgene, which can act as both a Cre deletor and reporter in 
the lacrimal gland epithelium, greatly facilitating the genetic analysis of its development 
(Ashery-Padan et al., 2000; Pan et al., 2008). Surprisingly, lacrimal gland defects have not 
been reported in human aniridia (OMIM 106210), a congenital disorder caused by 
heterozygous mutations in PAX6. Instead, patients with otofaciocervical syndrome-2 
carrying homozygous PAX1 mutations (OMIM 615560) display lacrimal duct abnormalities, 
a phenotype shared with the closely related otofaciocervical syndrome-1 (OMIM 601653) 
that harbors mutations in the EYA1 gene (Pohl et al., 2013). On the other hand, 
branchiootorenal syndrome-1 (BOR1, OMIM #113650) caused by heterozygous EYA1 
mutations and branchiootic syndrome-3 (OMIM #608389) caused by SIX1 heterodeficiency 
display many overlapping phenotypic traits including lacrimal gland stenosis, suggesting 
that these two genes may act in the same genetic cascade. Indeed, Six1 is found in both the 
duct and acini of the mouse lacrimal gland, and Six1 knockout embryos exhibit small 
lacrimal glands with poor duct elongation and reduced branching (Laclef et al., 2003). From 
Drosophila to mammals, Pax, Six and Eya genes have been shown to form a conserved 
transcriptional network in organogenesis, interactions that may conceivably still occur in 
lacrimal gland development.
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Whereas Pax/Six/Eya genes likely serve as competence factors for lacrimal gland 
development, additional transcription factors are required to specify the identity of the 
epithelium. TP63 is a transcription factor that is important for a variety of epithelial 
structures (Yang et al., 1999). Mutations in this gene abolish lacrimal gland development in 
mice, and cause Limb-mammary syndrome (OMIM 603543) associated with lacrimal-duct 
atresia and obstructed lacrimal puncta in humans (van Bokhoven et al., 2001). Otx1 is a 
homeodomain transcription factor expressed in the conjunctival epithelium and Otx1 
knockout mice fail to develop lacrimal glands (Acampora et al., 1996). In addition, loss of 
epithelial expression of Runx1 results in a delay in embryonic lacrimal gland development 
characterized by reduced branching and a smaller lacrimal bud at E16.5. It is likely that 
Runx1 is compensated in part by Runx2 and Runx3, which are also expressed during the 
time of lacrimal gland development (Voronov et al., 2013).
Certain transcription factors may regulate development of both the epithelial and 
mesenchymal compartments of the lacrimal gland. The majority of patients carrying 
heterozygous SOX10 mutations (Waardenburg syndrome, OMIM 611584 and 613266) have 
either a hypoplastic lacrimal gland or are lacking one entirely, underscoring the requirement 
of SOX10 for lacrimal gland genesis (Elmaleh-Berges et al., 2013). This finding is further 
supported by the finding that lacrimal gland defects are present in mice harboring a 
conditional deletion of Sox10 in the epithelium (Chen et al., 2014b). However, since Sox10 
is also expressed by migratory neural crest cells that eventually form the periocular 
mesenchyme, Sox10 may also indirectly regulate lacrimal gland induction by controlling 
neural crest migration and differentiation. Similarly, the TFAP2a mutations carried by 
Branchiooculofacial syndrome patients cause lacrimal duct obstruction (OMIM #113620). 
Given that Ap2a in the mouse is expressed in both the neural crest and surface ectoderm, we 
predict that human TFAP2a function may be required by both the mesenchyme and 
epithelium of the lacrimal gland.
Our current knowledge of lacrimal gland transcription factors is largely restricted to those 
that are active in the epithelium rather than in the mesenchyme. This is in part due to the fact 
that over 90% of the mature lacrimal gland is epithelial in origin. Mesenchymal 
condensation is one of the earliest events in lacrimal gland development, but its mechanism 
and functional significance remain poorly understood. Considering the importance of the 
mesenchyme in inducing the development of the lacrimal gland epithelium, more efforts 
should be devoted to understanding its specification and differentiation in the context of 
lacrimal gland development. In addition, many of the human congenital syndromes 
mentioned earlier affect the formation of the lacrimal puncta and canaliculi, which are 
structural components of the lacrimal outflow system rather than being part of the 
parenchymal ducts existing within the gland itself. In contrast, mouse studies have revealed 
far more genetic mutations directly disrupting the lacrimal gland itself. It is possible that 
subtle structural defects in human lacrimal glands, especially those affecting the lacrimal 
gland duct, are under-recognized because they are both difficult to diagnose and are 
obscured by the general dry eye symptoms. In contrast, obstruction of the excretory duct is 
more clinically apparent in its presentation. Further study of lacrimal gland abnormalities in 
animal models is therefore important to alert and inform clinicians to the potential sources 
and sites of pathology in various dry eye conditions in humans.
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Understanding lacrimal gland regeneration
Various secretory glandular systems including the salivary gland (Takahashi et al., 1998; 
Takahashi et al., 2004), pancreas (Mansouri, 2012) and mammary gland (Shackleton et al., 
2006) have at least a limited ability to self-renew after injury, a process that is mediated by 
tissue stem cells. Similar to these exocrine glands, the lacrimal gland has also been shown to 
have significant regenerative potential, raising the possibility that it may be feasible to 
design therapeutic strategies that take advantage of this feature. Important issues to consider 
in this context include the molecular cues that trigger regeneration, the signaling pathways 
involved in the process, the nature and origin of the stem and progenitor cells, and whether 
these cells can be isolated and expanded in culture.
Recent studies suggest that the mature lacrimal gland can exhibit a robust regeneration 
program as part of the wound healing process, displaying similar features found in lacrimal 
gland development. This was first observed in an injury model where the pro-inflammatory 
cytokine IL1 was injected into the extra-orbital lacrimal gland of adult mice (Zoukhri et al., 
2002; Zoukhri et al., 2007). Within 2–3 days of injection, a population of mesenchymal cells 
marked by the intermediate filament nestin proliferated to repair the injured gland. 
Interestingly, a subset of nestin-positive cells expressed α-SMA, a myoepithelial cell 
marker, suggesting a common origin of the acinar and myoepithelial cells involved in the 
repair process (Zoukhri et al., 2008). This finding is reminiscent of lacrimal gland 
development wherein common epithelial progenitors give rise to both acinar and 
myoepithelial cells. The injury and repair process was accompanied by an initial increase 
and subsequent decline of BMP signaling as indicated by changes in phospho-SMAD1/5/8 
levels (Zoukhri et al., 2008). There was also concomitant up-regulation of Runx genes, 
which, as mentioned previously, are known to regulate lacrimal gland development(Voronov 
et al., 2013). These studies highlight a conservation of developmental pathways during 
regeneration/repair.
A critical question to consider is the identity of the stem or progenitor cells responsible for 
lacrimal gland regeneration. Various studies have suggested that they could be of either 
mesenchymal, ductal, myoepithelial or acinar origin. The nestin-positive cells isolated from 
IL1-injected lacrimal glands can be expanded in vitro to form adipocytes with at least some 
of these cells expressing the mesenchymal stem cell (MSC) markers vimentin, ABCG2, and 
Sca1 (You et al., 2011). However, transcription factor Snail1, which is involved in the 
epithelial-mesenchymal transition (EMT), is also induced in the duct epithelial cells upon 
injury, suggesting that the duct cells may be a source of MSCs during repair (You et al., 
2012). In this regard, it is interesting to note that KRT15 is present throughout the lacrimal 
gland epithelium during embryonic development, but its expression in the adult lacrimal 
gland becomes restricted to a subset of basal cells surrounding the intercalated duct, a 
pattern resembling the stem cell niche reported in mammary and salivary glands (Hirayama 
et al., 2016). On the other hand, an immature stem-like population expressing the putative 
stem cell markers nestin, Mushahi1 and ABCG2 has been identified in the myoepithelium 
from the uninjured rat lacrimal gland. These cells can be expanded in culture and 
differentiated into multiple lineages, suggesting a myoepithelial origin for the intrinsic 
progenitor cells (Shatos et al., 2012). Single cells isolated from lacrimal gland epithelial cell 
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cultures have also been shown to possess sphere-forming capabilities characteristic of stem 
cells, but these cells did not express the myoepithelial marker α-SMA (Kobayashi et al., 
2012). Using cell surface markers (c-kit+Epcam−CD31−CD45−Sca1−), epithelial progenitor 
cells have been purified by FACS and shown to form organoids that differentiate into ductal 
and secretory cells in a 3D culture system (Gromova et al., 2017). Finally, presumptive stem 
cells expressing the pluripotency markers Sox2, Nanog, and Klf4 can be isolated from the 
adult mouse lacrimal gland, passaged multiple times in culture, and induced to express 
markers of all three germ layers (Ackermann et al., 2015). In the human lacrimal gland, 
stem-cell like cells positive for ABCG2, ALDH and c-kit have also been reported to form 
spheres in non-adherent cultures.
Taken together, the emerging consensus is that the adult lacrimal gland harbors endogenous 
stem or progenitor cells, but their identity and location remains controversial. Because the 
existing studies are limited to in vitro cultures and putative stem cell markers, they may not 
accurately characterize lacrimal gland stem cells in vivo. We suggest that studies of lacrimal 
gland regeneration would benefit from the genetic approaches that have propelled the studies 
of lacrimal gland development. We have previously used the Le-Cre driver to trace the 
lineage of the Pax6-expressing cells during lacrimal gland development, showing that they 
specifically reside in the lacrimal gland epithelium in new born mice (Pan et al., 2008). With 
the increasing repertoire of inducible Cre lines, similar lineage tracing techniques should be 
readily applicable in resolving the location and nature of the lacrimal gland stem cells.
Current advances in regenerative therapy for the dry eye disease
Given the lack of curative treatments for dry eye disease, regenerative medicine has emerged 
as a promising approach to provide more permanent and sustainable treatment options. For 
the treatment of dry eye disease, our understanding of developmental biology, stem cell 
biology, and the regenerative capacity of the lacrimal gland is of critical importance for 
advancing this field of medicine. Several studies have already indicated that resident stem or 
progenitor cells in the mature lacrimal gland can turn on the same signaling pathways and 
transcription factors used in embryonic development to drive proliferation and 
differentiation in the adult gland. Currently, two main strategies are being developed for 
lacrimal gland repair and regeneration: i) capitalizing on the intrinsic regenerative capacity 
of the lacrimal gland, and ii) developing bioengineered lacrimal glands for tissue 
replacement. Both strategies will require a detailed knowledge and understanding of lacrimal 
gland development and remodeling.
Promoting the intrinsic repair and regeneration of the lacrimal gland
Despite the uncertainty regarding the stem/progenitor cells in the adult lacrimal gland, there 
are significant efforts to develop pharmacological approaches that promote the intrinsic 
repair process of the gland. It has been shown that inflammation-induced injury causes 
apoptosis and autophagy, which then trigger the intrinsic repair process (Zoukhri, 2010). 
This has led to the idea that activating apoptosis through TNF-α agonists can potentially 
initiate in vivo regeneration of the injured lacrimal gland. In fact, the TNF-α-induced factor 
TSG-6 has been identified as the main cytokine responsible for the regenerative and 
immunomodulatory effects of mesenchymal stem cells in different tissues (Dietrich et al., 
Garg and Zhang Page 10
Dev Dyn. Author manuscript; available in PMC 2018 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
2016). Recently, topical administration of TSG-6 has been shown to improve tear production 
and ameliorate ocular surface defects in a mouse model of dry eye (Lee et al., 2015a). 
Similarly, injection of platelet-rich activated plasma into an adjacent region of the lacrimal 
gland has been reported to be safe and effective in promoting tear production in Sjogren’s 
syndrome patients, an effect that may be due to growth factors and cytokines present in the 
plasma (Avila, 2014). In this regard, it is notable that exogenous FGF2 has been shown to 
stimulate the repair of atrophic salivary glands in rats, and administration of BMP7 can 
preserve renal tubular function after acute and chronic kidney injury (Okazaki et al., 2000; 
Simic and Vukicevic, 2005). With the increasing understanding of FGF and BMP pathways 
in lacrimal gland development, their ligands and agonists can potentially be exploited to 
initiate or accelerate repair.
In addition to drug-based therapy, direct cell transplantation has also been explored. 
Mesenchymal stem cells (MSCs) derived from different sources, including bone marrow, 
adipose tissue, and glandular organs, are multipotent, non-immunogenic, and anti-
inflammatory (Dietrich et al., 2016). These properties are particularly attractive in conditions 
such as Sjogren’s syndrome, in which inflammation causes a significant decline in the 
functional capacity and regenerative potential of lacrimal gland progenitor cells (Umazume 
et al., 2015). There are several lines of evidence demonstrating the beneficial effects of 
administering MSC-like cells into the lacrimal gland. In a dry eye mouse model, periorbital 
injection of human MSCs led to a localized reduction in inflammatory cytokines and 
improved tear secretion (Lee et al., 2015b). Topical administration of MSCs in a rat model 
of the dry eye disease also improved tear volume and tear film stability (Beyazyildiz et al., 
2014). Recently, progenitor cells of the epithelial lineage from adult mouse lacrimal glands 
were successfully engrafted into the ductal and acinar compartments of chronically diseased 
lacrimal gland in TSP−/− mice, a model of Sjogren’s syndrome. This procedure partially 
restored the structural integrity of the lacrimal gland and improved tear secretion (Gromova 
et al., 2017). These results suggest that cell-based therapy is a promising approach for 
treating the aqueous-deficient dry eye diseases.
Developing bioengineered lacrimal gland for transplantation
In the case of extensive lacrimal gland damage, direct transplantation of a donor or 
bioengineered lacrimal gland may be the only viable approach. However, when considering 
these forms of therapy, graft rejection and scant supply of donors are frequent issues that 
arise (Abouna, 2008). A recent study has evaluated the feasibility of porcine lacrimal gland 
as a potential xenograft candidate for transplantation, identifying significant similarities in 
morphology, anatomical location and connection to vascular supply. Before being a more 
commonly accepted route of therapy, however, key challenges, which include immune 
rejection and differences in tear composition, will need to be resolved (Henker et al., 2013). 
For a bioengineered lacrimal gland, advances in stem cell biology and biomedical 
engineering have made it increasingly promising to consider generating replacement tissues 
in vitro. Its ultimate success, however, requires advances in two essential areas- i) creating 
an abundant source of lacrimal gland cells with intact secretory function, and ii) a 
biocompatible scaffold to provide the appropriate microenvironment and structural support 
for proper histogenesis.
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Sources of lacrimal gland cells—As a proof of principal, lacrimal gland germs have 
recently been reconstituted by combining mouse embryonic epithelial and mesenchymal 
cells in a gel matrix system (Hirayama et al., 2013). After engraftment into adult mice 
lacking the extra-orbital gland, these bioengineered germs grew and successfully restored 
lacrimation. Although these findings are highly promising, the use of embryonic tissue in a 
clinical setting is presently a grey area. Alternatively, the presence of adult lacrimal stem or 
progenitor cells may could be a feasible approach to reconstituting the lacrimal gland, if 
graft immune compatibility can be ensured.
The use of autologous induced pluripotent stem (IPS) cells can theoretically provide an 
unlimited supply of lacrimal gland cells without immunological complications. By providing 
appropriate growth factors and substrates that closely mimic the relevant environment during 
embryonic development, IPS cells have been successfully coaxed to differentiate into 
numerous cell types, including those constituting glandular organs such as the liver and 
pancreas (Pagliuca et al., 2014; Ishikawa et al., 2015; Pellegrini et al., 2015; Toyoda et al., 
2015). A similar strategy to that used for human embryonic stem cells (hESCs) (Lee et al., 
2007; Dincer et al., 2013; Leung et al., 2013) can be applied to IPS cells to derive lacrimal 
gland tissues. Based on data derived from the study of lacrimal gland development, we 
suggest that IPS cells can be induced to differentiate into 1) ocular ectodermal cells that will 
form precursors of the lacrimal gland epithelium, and 2) neural crest cells that will form the 
periocular lacrimal gland mesenchyme. Signaling molecules such as FGF10 and BMP7 can 
be used to promote branching morphogenesis of the epithelial cells and condensation of the 
mesenchymal cells, respectively. These processes can be monitored by the expression of 
PAX6 and OTX1 for the epithelium, and FOXC1 for the mesenchyme. Alternatively, direct 
conversion of the IPS cells could potentially be achieved by the forced expression of 
transcription factors that play important roles in lacrimal gland development. Indeed, it has 
been recently reported that overexpression of PAX6, FOXC1 and SIX1 induce hESCs to take 
on morphological and gene expression profiles that resemble the lacrimal gland epithelium 
(Hirayama et al., 2017). Although many technical hurdles remain, this study suggests that 
IPS cells may ultimately be programmable to differentiate into lacrimal gland cells.
The next challenge in establishing a reliable source of lacrimal gland cells is to expand them 
in culture and validate their cellular characteristics. Studies on primary acinar cells have 
shown that serum-free medium that contains an appropriate mixture of hormonal and growth 
factor supplements can preserve the cells’ differentiated morphology and secretory capacity 
in the presence of matrigel. Nonetheless, it should be noted that reduced cell proliferation 
was observed (Oliver et al., 1987; Hann et al., 1989; Hann et al., 1991). To optimize culture 
conditions, lacrimal gland epithelial cells from newborn mice were tested for growth factor 
responsiveness. Both epidermal growth factor (EGF) and hepatocyte growth factor (HGF) 
were found to promote cell viability and proliferation. Counter-intuitively, however, FGF10 
failed to produce any effect (Ueda et al., 2009). Another study, using rabbit lacrimal gland, 
showed that a combination of EGF, dihydrotestosterone (DHT) and matrigel was able to 
induce massive proliferation of acinar cells in serum-free Hepato Stim™ Medium (HSM) 
(Schonthal et al., 2000). These studies highlight the importance of medium formulations and 
substrate conditions for expanding and preserving functional lacrimal gland cells.
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Building the functional lacrimal gland—To produce lacrimal gland germ for surgical 
implantation, lacrimal gland cells need to be seeded on an appropriate substrate that supports 
their structure and function. Human amniotic membranes have been shown to promote rabbit 
lacrimal gland cells to form acini-like structures, but their secretory response diminished 
over time, possibly as a result of structural impairments contained within the membranes 
(Schrader et al., 2007). Studies have also described the reconstitution of mouse, rat, rabbit 
and human lacrimal gland epithelial cells on Matrigel to form cell aggregates, displaying the 
morphology and secretory function characteristic of lacrimal gland acini (Meneray et al., 
1994; Yoshino et al., 1995; Vanaken et al., 1998; Schechter et al., 2002; Ueda et al., 2009; 
Tiwari et al., 2012). However, because it is derived from mouse sarcoma tissue, there are 
obvious safety concerns associated with the use of Matrigel in a clinical setting (Kibbey, 
1994). Several polymer-based substrates have also been tested or their acting as a scaffold in 
lacrimal gland morphogenesis with varying degrees of success being achieved (Long et al., 
2006; Selvam et al., 2007a; Selvam et al., 2007b; Selvam et al., 2009). Long-term functional 
studies will be needed to evaluate the efficacy and stability of the engineered tissues.
Human lacrimal gland is organized into a three dimensional structure that is well adapted for 
its secretory function. To more closely mimic this configuration, lacrimal gland acinar cells 
from rabbit have been cultured in a microgravity bioreactor to form lacrimal spheroids. 
However, following a two week period, continuous cell death was frequently displayed 
(Schrader et al., 2009). The same group recently described a non-immunogenic 
decellularized tissue matrix derived from pig lacrimal gland, which allows lacrimal gland 
epithelial cells seeded on this scaffold to maintain acinar-like structures and secretory ability 
for up to 30 days (Spaniol et al., 2015). In a similar effort, rabbit lacrimal gland progenitor 
cells derived from a sphere-forming culture have been shown to differentiate and display 
secretory function in either a decellularized lacrimal gland matrix or 3-D collagen gel (Lin et 
al., 2016). There are still challenges regarding optimization of the decellularization 
technique, the seeding process, the long-term culturing conditions, and functional validation. 
It is notable, however, that a lacrimal outflow duct constructed using acellular bovine dermal 
matrix has been successfully transplanted into patients to relieve obstructive signs and 
symptoms (Chen et al., 2014a). Through providing effective mechanical strength, the 
appropriate micro-environment for lacrimal gland cells, and the necessary structural support 
for vascular, nerve and ductal supply, the decellularized matrix promises to be an ideal 
scaffold for bioengineered lacrimal gland.
Summary and future research
Aqueous-deficient dry eye disease is a major health challenge that lacks effective treatment. 
Although lacrimal gland transplantation is a potentially promising course of treatment, it is 
plagued by immunological complications and donor shortage. Development of fully 
functional bioengineered lacrimal glands in vitro is a viable approach to repair damaged 
lacrimal glands, while stimulation of the intrinsic regenerative potential of the lacrimal gland 
also holds great promise. Both therapeutic strategies require a deeper understanding of 
development and regeneration of the gland. From the development perspective, we still have 
several unanswered questions: 1) how do the common epithelial progenitor cells gives rise to 
the acinar, ductal and myoepithelial cells, 2) how is the lacrimal gland mesenchyme 
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specified from the neural crest cells, and 3) what factors are required for adult lacrimal gland 
homeostasis? Additional work is also needed to reveal the signaling cascades that underlie 
gland morphogenesis, and the transcriptional network that ultimately determines the tissue 
identity and cell lineage for repair and regeneration. Those studies will pave the way to 
realizing the full potential of regenerative medicine to treat dry eye disease.
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Key Findings
1. Abnormalities of the lacrimal gland underlie aqueous-deficient dry eye 
disease.
2. FGF signaling is the key regulator of lacrimal gland morphogenesis.
3. The adult lacrimal gland harbors intrinsic stem or progenitor cells.
4. Developmental mechanisms can guide efforts in lacrimal gland regeneration.
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Figure 1. Schematic of Lacrimal gland functional unit
The lacrimal gland functional unit is comprised of a) the lacrimal gland, b) Sensory afferent 
nerves from the cornea and conjunctiva, c) motor efferent nerves originating from the central 
nervous system which innervate lacrimal gland, d) the excretory tear duct for drainage of the 
excess fluid. Impairment in any components of lacrimal gland function unit can destabilize 
the tear film and cause the dry eye disease.
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Figure 2. Lacrimal gland development in mouse
Transverse sections of mouse embryos at different stages are shown. Lacrimal gland 
development begins with thickening of the CE at E13.5 induced by Fgf10 from the 
surrounding mesenchyme. These epithelial cells further grow and elongate into a bud from 
E14.5 through E15.5. Branching of LG initiates at E16.5 under the additional influence of 
BMP7 signaling, eventually forming a multi-lobular tubulo-acinar structure at E19.5. 
Lacrimal gland continues to develop even during post-natal stages to become a mature gland 
capable of regulated tear secretion in adults. L: lens, R: Retina, CE: conjunctival epithelium, 
LG: lacrimal gland.
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Figure 3. Summary of signaling interactions during lacrimal gland morphogenesis
(Left) Fgf10 forms a heparan sulfates (HS)-dependent gradient in the periocular 
mesenchyme, inducing lacrimal gland budding by binding to both Fgfr2b and HS in the 
epithelium. This activates Shp2, which inhibits the Ras signaling repressor Spry2 and 
promotes Ras-Erk cascade to stimulate cell proliferation, survival and bud elongation. With 
transcription factors Sox9 and Barx2, FGF signaling also stimulates expressions of HS 
synthesizing enzymes (HSSE) and metalloproteinases to remodel the ECM, forming a 
positive feedback loop to enhance FGF signaling activity. (Right) Bmp7 signaling mediated 
by Foxc1 is important for mesenchymal condensation during branching morphogenesis. 
Both FGF and BMP signaling are counterbalanced by canonical Wnt signaling in the 
mesenchyme. In addition, Smad4-mediated BMP signaling and Sox9-Sox10 cascade also 
directly regulates the epithelial elongation.
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Table 1
Transcription factors implicated during lacrimal gland development and maintenance.
Genes
Functional relevance during Lacrimal gland development
Mice Phenotype in humans
Pax6 Budding, competence factor Not reported
Pax1 Not studied Lacrimal duct stenosis
Eya1 Not studied Lacrimal gland aplasia, duct stenosis
Six1 Branching morphogenesis Lacrimal duct stenosis
Otx1 Budding Not reported
p63 Budding Lacrimal-duct atresia, obstructed lacrimal puncta
Runx1–3 Branching morphogenesis Not reported
Klf5 Preservation of glandular function during post-natal stages Not reported
Sox10 Growth and branching morphogenesis Hypo-plastic or no lacrimal gland
Ap2α Not studied Lacrimal duct obstruction
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